Deproteinized Bovine Bone in Alveolar Bone Critical Size Defect (>2cm) Secondary to Cyst Removal
Launched by UNIVERSITY OF PADOVA, SCHOOL OF DENTAL MEDICINE · Nov 23, 2015
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
The healing of extensive alveolar bone defects secondary to cyst removal is not predictable. Residual voids of various entity may persist. Some Authors proposed the use of grafting materials to reconstitute the loss of hard tissue. The primary objective was to determine the efficacy of bone grafting.The secondary objectives were to evaluate the incidence rate of wound dehiscence, pus drainage, recurrence and other complications 7 and 30 days and 6 months after surgery. Recurrence at 12 months of healing was also evaluated. For all patients included, surgeries were performed in conscious sed...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • no smoking for at least 6 months;
- • preoperative radiological diagnosis of radiolucent lesion of probable cystic origin;
- • bone defect \> 2 cm (diameter);
- • ASA1;
- • consent to the study inclusion.
- Exclusion Criteria:
- • subjects in need of treatment with a hemostatic material;
- • active infection or inflammation in the treatment area;
- • uncontrolled diabetes;
- • bone diseases ( Paget's disease, patients undergoing bisphosphonate therapy, multiple myeloma, bone metastases);
- • previous radiation therapy in the head and neck region;
- • patients not able to take part to the follow-up program.
About University Of Padova, School Of Dental Medicine
The University of Padova, School of Dental Medicine, is a prestigious academic institution dedicated to advancing dental research and education. With a strong emphasis on innovative clinical practices and interdisciplinary collaboration, the School actively engages in conducting clinical trials aimed at improving oral health outcomes. Leveraging a team of experienced researchers and clinicians, the institution fosters an environment of scientific inquiry and excellence, contributing significantly to the field of dentistry through evidence-based practices and the exploration of novel therapeutic approaches.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials